Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care
ConditionSciatica Acute
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
The goal of this clinical trial is to compare transgluteal sciatic nerve block to standard of care to treat sciatic back pain in adult patients who present to the emergency department.
The main question it aims to answer is: Is a transgluteal sciatic nerve block better than standard of care in improving pain in ER patients with sciatic back pain?
If there is a comparison group: Researchers will compare patients who receive transgluteal sciatic nerve blocks to patients who receive standard of care to see if pain scores improve in ER patients with sciatic back pain.
Participants will be randomized into the transgluteal sciatic nerve block group or the control group (standard of care). Participants will be asked to answer questions about their pain and will be asked to walk a timed short distance.
Eligibility criteria
Qualifiers
Adults aged 18 years and older
Acute or acute-on-chronic pain consistent with sciatica, defined as unilateral lumbosacral radicular pain radiating from the lower back or gluteal region to the posterior leg, may extend distal to the knee.
Pain score ≥ 5/10 on Numeric Rating Scale (NRS)
Disqualifiers
Known allergy to study medications (e.g., local anesthetics)
Coagulopathy or current anticoagulation therapy
Suspected or confirmed spinal infection, or tumor
Neurological deficits (bowel or bladder dysfunction, leg weakness)
Trial design
Treatments tested in this trial
- nerve block with ropivacaine
- Standard medical treatment
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov